Oncotelic Leads Biotech Innovation with AI and Nanomedicine for Cancer
September 17, 2025 — Oncotelic Therapeutics advances cancer and rare disease treatments using AI and nanomedicine, joining innovators like Merck and AstraZeneca in transforming patient care.